收藏 分销(赏)

中国细菌耐药性现状(英文版).ppt

上传人:w****g 文档编号:14673193 上传时间:2026-10-27 格式:PPT 页数:41 大小:3.96MB 下载积分:10 金币
下载 相关
中国细菌耐药性现状(英文版).ppt_第1页
第1页 / 共41页
中国细菌耐药性现状(英文版).ppt_第2页
第2页 / 共41页


点击查看更多>>
资源描述
单击此处编辑母版标题样式,*,单击此处编辑母版文本样式,第二级,第三级,第四级,第五级,Bacterial Resistance in China,Minggui Wang,M.D.,Institute of Antibiotics,Huashan Hospital,Fudan University,Outline,Antimicrobial Resistance and Its Mechanisms,Gram-positive cocci,Streptococcus pneumoniae,Staphylococcus spp.,Gram-negative bacilli,Enterobacteriaceae,Escherichia coli,Klebsiella spp.,Enterobacter spp,.,et al.,Non-fermenting gram-negative bacilli,(non-fermenters),Antimicrobial Resistance,in,Streptococcus pneumoniae,History of studies on antimicrobial resistance on,Streptococcus pneumoniae,19671970 1978 1980 1991 2001,Spread around the world,First case of,PRSP,First case of,MDR,Mechanism of,PRSP,Regional problem,Global problem,-lactams(penicillin),Macrolides,Fluoroquinolones,Penicillin resistance in,S.pneumoniae,in China in early 2000,Year,Region,Population,Source,No.of Strains,PNSSP,(%),PISP,(%),PRSP,(%),2001,Shanghai,Children,Clinical,100,55,49,6,01-02,Beijing,Shenyang,Clinical,192,43,32,11,00-02,3 centers,Children,Clinical,887,40,34,6,00-01,4 centers,Children,Clinical,624,41,37,4,PNSSP,penicillin non-susceptible,S.pneumoniae,;PISP,penicillin intermediate,S.pneumoniae,;,PRSP,penicillin resistant,S.pneumoniae,Penicillin resistance in,S.pneumoniae,has been increasing markedly since 2000,Increasing trends of,Penicillin resistance in,S.pneumoniae,in China,Shanghai,100 strains each year,Beijing,More than 100 strains each year,Clinical strains isolated from Childrens Hospital,Reasons causing the rapid increasing of penicillin resistance,The increasing consumption of oral penicillins such as amoxicillin,The spead of,resistant,colonines,Resistance of,S.pneumoniae,to macrolides,70%-90%,of,S.pneumoniae,clinical isolates were resistant to erythromycin,Antimicrobial resistance of,S.pneumoniae,isolated from children in Beijing,Shanghai,Guangzhou and Xian(20002001),Mechanisms of resistance to macrolides,(Wang M.Diagn Microbial Infect Dis 2001;39:187),Target modification,Phenotype cMLS,90%,(159/176),Phenotype iMLS,6%,(10/176),Active efflux,Phenotype M,4%,(7/176),Trends of methicillin resistant,Staphylococcus,spp.(MRS)in China,5%-24%,35%-60%,50%-70%,Mechanism of MRSA,MRSA contain novel,PBP2a,substitutes for native PBPs;low affinity for all,-lactams,PBP2a is encoded by,mecA,gene;expression controlled by mecI,mecR1 and other factors,Antimicrobial Resistance,in,Enterobacteriaceae,Antimicrobial resistance rates of,E.coli,isolated in China in 2005(n=3758),Wang F.Chin J Infect Chemother 2006;6:289,Antimicrobial resistance rates of,K.pneumoniae,in China in 2005(n=2234),Wang F.Chin J Infect Chemother 2006;6:289,Extended-spectrum,-lactamases(ESBLs),in Enterobacteriaceae in China,ESBL-producing strains,Hospital-acquired infections,1,:,E.coli,11-47%,K.pneumoniae,14-51%,Community-acquired infections,2,:,E.coli,16%,K.pneumoniae,17%,The main genotype of ESBLs is,CTX-M,1,typically provides resistance to ceftaxime but often not to ceftazidime or aztreonam,3,1,Xiong Z.Diagn Microbiol Infect Dis 2002;44:195,2,Ling TK.AAC 2006;50:374,3,Jacoby GA.Chin J Infect Chemother 2006;6:361,Quinolone resistance rates in clinical isolates of,E.coli,in Shanghai,Plasmid-mediated quinolone resistance:,qnr,determinats,R,S,R,R,S,R,Conjugation,Transformation,R,qnr,qnrA,:Lancet,1998,the U.S.,qnrB,:AAC,2006,the U.S.,qnrS,:AAC,2005,Japan,qnrC,:7,th,NCCM,2007,China,Plasmid-mediated quinolone resistance,qnr,family:,qnrA,qnrB,qnrS,qnrC,Protection of quinolone targets,aac(6)-Ib-cr,(2006),aminoglycoside acetyltransferase,qepA,(2007),q,uinolone,e,fflux,p,ump,Summary,Antimicrobial resistance in gram-negative bacilli,ESBLs-producing strains of,E.coli,and,K.pneumoniae,are common,and spreading from hospital to community,Quinolone resistance rates in,E.coli,are especially high,New mechanisms of plasmid-mediated quinolone resistance emerged,Importance of non-fermenters,Non-fermenting gram-negative bacilli(non-fermenters)include:,Pseudomonas aeruginosa,Acinetobacter,spp.,Stenotrophomonas maltophilia,Alcaligenes,spp.,Burkholderia,spp,Flavobacterium,(,Chryseobaterium,)spp.,et al,Non-fermenters are highly resistant to commonly used antimicrobials,The infections of non-fermenters are difficult to treat with high mortality,Percentage of non-fermenters in gram-negative bacilli in Shanghai hospitals,(,Wang F,et al.Int J Antimicrob Agents 2003;22:444),1460,1632,1215,1171,1369,1661,2028,3028,3275,3005,5242,5656,4818,5819,5665,Year,No of strains,Resistance pro 6123 strains of non-fermenters against 8 antimicrobials in CHINET in 2005,(Wang F.Chin J Infect Chemother 2006;6:289),Antimicrobial agents,Resistance rate(%),Susceptibility rate(%),Ceftazidime,41,52,Cefepime,45,46,Piperacillin-tazobactam,44,49,Cefoperazone-sulbactam,23,52,Imipenem,43,54,Meropenem,43,55,Ciprofloxacin,41,48,Amikacin,46,48,Trends in antimicrobial resistance rates among strains of,P.aeruginosa,isolated from Shanghai hospitals(%),Antimicrobial agents,1993*,(232),2000,(1790),2001,(2302),2002,(2457),2003,(2123),2004,(2287),2005,(2520),Piperacillin,24,31,33,30,33,33,34,Ceftazidime,8,17,21,20,20,24,19,Cefoperazone,20,26,30,29,30,31,28,Cefepime,-,-,17,16,17,17,15,Piperacillin-tazobactam,-,-,29,27,26,26,24,Ticarcillin-clavulanic acid,-,37,47,47,37,43,38,Cefoperazone-sulbactam,-,15,15,14,15,15,13,Imipenem,6,17,24,26,25,21,21,Meropenem,-,14,21,-,17,24,23,Gentamicin,36,33,34,35,38,33,32,Amikacin,8,20,23,21,20,20,17,Ciprofloxacin,13,28,27,19,25,21,24,*Testing year,number of isolates in the parentheses,Mechanisms of resistance to imipenem in,P.aeruginosa,Producing of,-lactamases:,carbapenemases,IMP,VIM,OXA,KPC,GIM,SPM families,ESBLs,AmpC,Decreased permeability:lost of porin D2,Active efflux,X,Efflux,Inactivation,Decreased,permeability,Trends in antimicrobial resistance rates among strains of,Acinetobacter spp.,isolated from Shanghai hospitals(%),Antimicrobial agents,1999*,(1199),2000,(1365),2001,(1851),2002,(2056),2003,(1686),2004,(2191),2005,(2418),Piperacillin,41,51,44,42,49,52,57,Ceftazidime,40,46,30,38,43,45,50,Cefoperazone,64,-,57,59,65,79,-,Cefepime,-,33,29,29,35,37,43,Piperacillin-tazobactam,19,-,20,27,30,32,37,Ampicillin-sulbactam,11,16,19,21,19,22,30,Cefoperazone-sulbactam,-,-,5,6,8,9,14,Imipenem,4,3,3,2,4,4,10,Meropenem,-,4,3,-,5,6,11,Gentamicin,42,49,42,41,46,50,54,Amikacin,31,33,31,31,33,36,41,Ciprofloxacin,37,45,37,38,42,46,50,*Testing year,number of isolates in the parentheses,Antimicrobial resistance rates among ICU strains of,Acinetobacter,spp.in China between 2003 and 2004(%),(,Wang H,et al.Chin J Lab Med 2005;28:1295),Antimicrobial agents,2003,2004,Ceftazidime,47,50,Cefepime,51,52,Piperacillin-tazobactam,27,30,Cefoperazone-sulbactam,11,13,Imipenem,4.5,18,Meropenem,4.5,17,Amikacin,41,52,Ciprofloxacin,53,59,Outbreak of carbapenem-resistant,A.baumannii,in Beijing and Guangzhou,(Wang H,et al.Chin J Lab Med 2005;28:636),MDR-AB,resistant to 3 of the following 5 drugs:Pip/TAZ,CAZ,Sul/CFP,Gen,Cip,Imi,5%in 1995 67%in 2002 in BJ,20%in 1998 57%in 2002 in GZ,90%(35/39)strains produced,OXA-23,carbapenemase,PFGE results indicated resistance colonies spread in each of 4 hospitals,mainly in patients with VAP and surgical infections,Lane 1-3,5,8,11-16 PFGE type A,indicating same colony,Outbreak of COS-AB in Shanghai,(Yang L,et al.Natl Med J China 2006;86:592),Outbreak of COS-AB(colistin-only-sensitive,A.baumannii,)in some hospitals,PFGE type B strains caused outbreak of COS-AB in burn ward in a Shanghai hospital,PFGE type A strains of COS-AB spread in surgical wards,Lane 5-10,13-14,PFGE type A,Lane 3-4,12,PFGE type B,Trends in antimicrobial resistance rates among strains of,S.maltophilia,isolated from Shanghai hospitals(%),Antimicrobial agents,1999*,(271),2000,(323),2001,(581),2002,(573),2003,(448),2004,(583),2005,(751),Piperacillin,69,77,59,65,68,74,73,Ceftazidime,53,37,33,40,38,38,37,Cefoperazone,38,27,22,33,33,44,42,Cefepime,-,-,36,49,38,46,48,Piperacillin-tazobactam,-,-,40,51,56,57,53,Ticarcillin-clavulanic acid,36,23,13,33,26,30,35,Cefoperazone-sulbactam,-,14,9,18,17,18,22,Imipenem,91,96,96,98,98,98,97,Meropenem,-,89,65,50,79,85,83,Gentamicin,70,75,74,78,76,79,76,Amikacin,68,75,75,78,71,75,68,Ciprofloxacin,13,18,17,12,13,19,22,Trimethoprim-sulfamethoxazole,31,24,15,13,31,21,20,Summary,Antimicrobial resistance in non-fermenters,The isolation of non-fermenters has been increasing in recent years,The resistance rates of non-fermenters have been increasing,More than 20%strains of,P.aeruginosa,are resistant to imipenem,There were reports of outbreak of carbapenem-resistant,A.baumannii,Conclusions,Antimicrobial resistance becomes a big problem in the field of Infectious Diseases in China,Rational use of antimicrobials is the most important way to decrease or hinder antimicrobial resistance,Huashan Hospital,Bird View,THANK YOU,
展开阅读全文

开通  VIP、SVIP  下载更划算
下载10份以上建议开通 VIP 会员
下载20份以上建议开通SVIP会员


开通VIP      成为共赢上传

当前位置:首页 > 包罗万象 > 大杂烩

移动网页_全站_页脚广告1

关于我们      便捷服务       自信AI       AI导航        关注我们

©2010-2026 宁波自信网络信息技术有限公司  版权所有

客服电话:0574-28810668  投诉电话:18658249818

gongan.png浙公网安备33021202000488号   

icp.png浙ICP备2021020529号-1  |  浙B2-20240490  

关注我们 :微信公众号    抖音    微博    LOFTER 

客服